Factor VII and Fibrinogen Levels Examined by Age, Sex, and other Atherosclerotic Risk Factors in a Japanese Population

Summary

Factor VII coagulant activity (FVIIc) and fibrinogen (Fbg) levels have been investigated as cardiovascular risk factors. We studied these two factors with stratification for age, sex and blood pressure, and the relation with other atherosclerotic risk factors in a Japanese general population. The subjects were 3,139 Japanese (1,315 males and 1,824 females) aged 30 to 89 in 1992 and 1993. A linear increase with age was observed in the levels of Fbg in both men and women, but no differences were observed between men and women in each age group. A linear increase with age was also seen in the levels of FVIIc in women, but the levels of FVIIc in men were significantly higher for the age group 40-49 years than for any other age group. The levels of FVIIc in women were significantly higher than in men at age ≥60 years. As concerning the effect of alcohol intake status, Fbg had a tendency to decrease with alcohol intake. Fbg and FVIIc levels were associated with an increase in smoking status in men, but no association was seen in women in either Fbg or FVIIc. FVIIc was positively correlated with age, body mass index, total cholesterol, triglycerides and fasting insulin level. Fbg was positively correlated with age, systolic blood pressure, diastolic blood pressure, total cholesterol, LDL-cholesterol and triglycerides in women, but Fbg had few positive correlations with risk factors in men.

A comparison with previous Western studies showed that the Fbg levels of our Japanese population were lower than those of the Caucasians studied, but the present FVIIc levels were nearly the same level or slightly higher than theirs. The association of Fbg and FVIIc and with other cardiovascular risk factors in Japanese was similar to those observed in Caucasians.

• References

• 1 Wilhelmsen L, Svadsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
• 2 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2 (8506): 533-537
• 3 Kannel W, Wolf P, Castelli W, D’Agostino R. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258 9: 1183-1186
• 4 Balleisen L, Bailey J, Epping PH, Schulte H, Van deLoo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: Baseline date on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 1985; 54: 475-479
• 5 Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study. J Clin Epidemiol 1990; 9 (09) 913-919
• 6 Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91 (03) 191-205
• 7 Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the Second MONICA Augsburg Survey, 1989 to 1990. Arterioscler Thromb 1992; 12: 780-788
• 8 Yeh CJ, Pan WH, Bai CH, You MS, Wang WC, Wang LY, Lee TK. Curvilinear relations between age and hemostatic parameters in Chinese. Thromb Haemost 1994; 72 (02) 239-243
• 9 Kario K, Matsuo T, Nakao K. Factor VII hyperactivity in the elderly. Thromb Haemost 1991; 65 (01) 25-27
• 10 Iso H, Folsom AR, Wu KK, Finch A, Munger RG, Sato S, Shimamoto T, Terao A, Komachi Y. Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, and von Willebrand factor and their relations to cadiovascular disease risk factors. American Journal of Epidemiology 1989; 130: 925-934
• 11 Iso H, Folsom AR, Sato S, Wu KK, Shimamoto T, Koike K, Iida M, Komachi Y. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscler Thromb 1993; 13: 783-790
• 12 Nago N, Kayaba K, Hiraoka J, Matsuo H, Goto T, Kario K, Tsutsumi A, Nakamura Y, Igarashi M. Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study. Am J Epidemiol 1995; 141 (09) 815-821
• 13 Goto T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, Nagoh N, Kayaba K, Yamada S, Matsuo H, Hosoe M, Itoh Y, Kawai T, Igarashi M, Shimada K. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography. Am J Cardiol 1995; 76: 928-932
• 14 Kario K, Narita N, Matsuo T, Matsuo T, Kayaba K, Tsutsumi A, Matsuo M, Miyata T, Shimada K. Genetic determinants of plasma factor VII activity in the Japanese. Thromb Haemost 1995; 73 (04) 617-622
• 15 Kario KNago, Kayaba K, Saegusa T, Matsuo H, Goto T, Tsutstumi A, Ishikawa S, Kuroda T, Miyamoto T, Matsuo T, Shimada K. Charactaristics of the insulin resistance syndrome in a Japanese population: The Jichi Medical School (JMS) Cohort Study. Arterioscler Thromb Vase Biol 1996; 16: 269-274
• 16 Kannel WB, Sorlie P. Some health benefits of physical activity. The Framingham Study. Arch Intern Med 1979; 139: 857-861
• 17 Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the poparative ultracentrifuge. Clin Chem 1972; 18: 499-502
• 18 Wilkes HC, Kelleher C, Meade TW. Smoking and plasma fibrinogen. Lancet 1988; 1: 307-308
• 19 Eliasson M, Evrin P-E, Lundblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study. J Clin Epidemiol 1994; 47 (05) 513-524
• 20 Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care 1991; 14 (06) 461-469
• 21 Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334 (15) 952-957
• 22 Marckmann P, Sandstrom B, Jespersen J. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fbrinolysis. Atherosclerosis 1993; 101: 225-234
• 23 Connelly JB, Roderick PJ, Cooper JA, Meade TW, Miller GJ. Positive association between self-reported fatty food consumption and factor VII coagulant activity, a risk factor for coronary heart disease, in 4246 middle-aged men. Thromb Haemost 1993; 70 (02) 250-252
• 24 Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ, Tracy RP. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly, The Cardiovascular Health Study. Am J Epidemiol 1996; 143: 665-676